| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CID-5951923 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | 0.0094 | 0.8 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | 0.013 | 0.8 |
| mRNA | CP724714 | GDSC1000 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | BMS-345541 | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | Sorafenib | FIMM | pan-cancer | AAC | -0.045 | 0.8 |
| mRNA | BRD-K66453893 | CTRPv2 | pan-cancer | AAC | 0.0085 | 0.8 |
| mRNA | Bicalutamide | GDSC1000 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | LFM-A13 | GDSC1000 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | BRD-K02251932 | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |